Uploaded February 2026 | Updated September 2026, 1 week ago
For extra nuances and references, see the associated written content: staycuriousmetabolism.substack.com/p/peter-attia-is-hiding-something-not?r=40ekz2
To enjoy many more deep dives on heart health, see the Heart Health Library at the Best-Selling in Science StayCurious Metabolism newsletter: staycuriousmetabolism.substack.com/p/hearthealth
The original video cover these data on this channel: youtu.be/6NomrgjK1yQ
Prior response to Peter Attia, Pitting Facts Against Sensationalism Regarding the Role of LDL Cholesterol in ASCVD: staycuriousmetabolism.substack.com/p/pitting-facts-against-sensationalism?r=40ekz2
Description
Statins are among the most prescribed and profitable drugs in history—but how often do we fully examine the data behind them? In this video, I respond to a rebuttal by Peter Attia concerning a controlled human trial published in Cell Metabolism showing a striking reduction in GLP-1 levels in people taking atorvastatin, alongside worsening glycemic markers. I highlight why the omission of a central graph undermines his rebuttal and scientific argument.
This is not an argument against statins per se, nor a personal critique. It’s a case study in how scientific conversations unfold, how data can be selectively emphasized, and why shared decision-making depends on full disclosure. We’ll dig into physiology, logic, and incentive structures that shape what information reaches clinicians and patients.
If you want a deeper dive, the full written analysis is linked above. This video is about curiosity, accountability, and building a healthier intellectual ecosystem around medicine—one honest conversation at a time.
Chapters
0:00 – Peter Attia is Hiding Something…
1:13 – What This Video is About. And What It’s Not About
2:15 – Establishing Context: Who is Responding to Who?
4:01 – What the Statin-GLP-1 Controlled Trial Shows A Category Error Explained
5:13 – My Real Concern is Not GLP-1. It Is…
6:29 – Truth 1: Absence of Evidence vs Evidence of Absence
7:56 – Truth 2: Incentive Structures Shape Medical Research
9:24 – Truth 3: Trust, Transparency, and Informed Consent
10:27 – A Personal Reflection on Scientific Discourse
13:12 – A Big Thank You to YOU
#statins #cholesterol #GLP1 #metabolichealth #medicine #medicalresearch #sciencecommunication #precisionmedicine #endocrinology #cardiology #diabetes #insulinresistance #clinicaltrials #evidencebasedmedicine #healthpolicy #pharma #biochemistry #physiology #scientificdebate #informedconsent #doctorpatient #healthcare #publichealth #medicalethics #nutrition #longevity #healthscience #academicmedicine #researchmethods #criticalthinking #dataanalysis #cellmetabolism #statinsideeffects #healthdiscussion #scienceyoutube #medtwitter #staycurious #healthliteracy #medicaleducation #trustinscience #transparency
For extra nuances and references, see the associated written content: staycuriousmetabolism.substack.com/p/peter-attia-is-hiding-something-not?r=40ekz2
To enjoy many more deep dives on heart health, see the Heart Health Library at the Best-Selling in Science StayCurious Metabolism newsletter: staycuriousmetabolism.substack.com/p/hearthealth
The original video cover these data on this channel: youtu.be/6NomrgjK1yQ
Prior response to Peter Attia, Pitting Facts Against Sensationalism Regarding the Role of LDL Cholesterol in ASCVD: staycuriousmetabolism.substack.com/p/pitting-facts-against-sensationalism?r=40ekz2
Description
Statins are among the most prescribed and profitable drugs in history—but how often do we fully examine the data behind them? In this video, I respond to a rebuttal by Peter Attia concerning a controlled human trial published in Cell Metabolism showing a striking reduction in GLP-1 levels in people taking atorvastatin, alongside worsening glycemic markers. I highlight why the omission of a central graph undermines his rebuttal and scientific argument.
This is not an argument against statins per se, nor a personal critique. It’s a case study in how scientific conversations unfold, how data can be selectively emphasized, and why shared decision-making depends on full disclosure. We’ll dig into physiology, logic, and incentive structures that shape what information reaches clinicians and patients.
If you want a deeper dive, the full written analysis is linked above. This video is about curiosity, accountability, and building a healthier intellectual ecosystem around medicine—one honest conversation at a time.
Chapters
0:00 – Peter Attia is Hiding Something…
1:13 – What This Video is About. And What It’s Not About
2:15 – Establishing Context: Who is Responding to Who?
4:01 – What the Statin-GLP-1 Controlled Trial Shows A Category Error Explained
5:13 – My Real Concern is Not GLP-1. It Is…
6:29 – Truth 1: Absence of Evidence vs Evidence of Absence
7:56 – Truth 2: Incentive Structures Shape Medical Research
9:24 – Truth 3: Trust, Transparency, and Informed Consent
10:27 – A Personal Reflection on Scientific Discourse
13:12 – A Big Thank You to YOU
#statins #cholesterol #GLP1 #metabolichealth #medicine #medicalresearch #sciencecommunication #precisionmedicine #endocrinology #cardiology #diabetes #insulinresistance #clinicaltrials #evidencebasedmedicine #healthpolicy #pharma #biochemistry #physiology #scientificdebate #informedconsent #doctorpatient #healthcare #publichealth #medicalethics #nutrition #longevity #healthscience #academicmedicine #researchmethods #criticalthinking #dataanalysis #cellmetabolism #statinsideeffects #healthdiscussion #scienceyoutube #medtwitter #staycurious #healthliteracy #medicaleducation #trustinscience #transparency
